Receptor for advanced glycation endproducts and progressive kidney disease

Acute Renal Failure in Critically Ill Patients A Multinational, Multicenter Study

Uchino, S. (2005) · JAMA · doi:10.1001/jama.294.7.813 · Cited by 4,183 · see citing works

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839 · see citing works

Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications

Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,512 · see citing works

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441 · see citing works

RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · see citing works

Systemic Lupus Erythematosus

Rahman, A., & Isenberg, D. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra071297 · Cited by 1,633 · see citing works

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,542 · see citing works

Body Mass Index and Risk for End-Stage Renal Disease

Hsu, C.-Y., McCulloch, C. E., Iribarren, C., Darbinian, J., & Go, A. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-1-200601030-00006 · Cited by 1,390 · see citing works

Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372 · see citing works

Obesity-related glomerulopathy: An emerging epidemic

Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J., & D’Agati, V. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041498.x · Cited by 1,279 · see citing works

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,256 · see citing works

Reversing established sepsis with antagonists of endogenous high-mobility group box 1

Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126 · see citing works

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

Schmidt, A. M., Yan, S. D., Yan, S. F., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200114002 · Cited by 1,039 · see citing works

Review: history of the amyloid fibril.

Sipe, J., & Cohen, A. B. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4221 · Cited by 1,037 · see citing works

The Kidney, Hypertension, and Obesity

Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000052314.95497.78 · Cited by 868 · see citing works

Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.

Schmidt, A. M., Vianna, M., Gerlach, M. L., Brett, J., Ryan, J., Kao, J. J., Esposito, C., Hegarty, H. M., Hurley, W. L., & Clauss, M. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42137-0 · Cited by 833 · see citing works

Section 2: AKI Definition

(2012) · Kidney International Supplements · doi:10.1038/kisup.2011.32 · Cited by 768 · see citing works

RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic Nephropathy

Wendt, T., Tanji, N., Guo, J., Kislinger, T., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L., Moser, B., Markowitz, G. S., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 599 · see citing works

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

Liliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M. E., Hofer, S., Plachky, J., Gröne, H.-J., Kurschus, F. C., Schmidt, A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18704 · Cited by 525 · see citing works

Mechanisms of Cardiac and Renal Dysfunction in Patients Dying of Sepsis

Takasu, O., Gaut, J. P., Watanabe, E., To, K. B., Fagley, R. E., Sato, B., Jarman, S., Efimov, I. R., Janks, D., Srivastava, A., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-1983oc · Cited by 515 · see citing works

Expression of Advanced Glycation End Products and Their Cellular Receptor RAGE in Diabetic Nephropathy and Nondiabetic Renal Disease

Tanji, N., Markowitz, G. S., Fu, C., Kislinger, T., Taguchi, A., Pischetsrieder, M., Stern, D. M., Schmidt, A. M., & D’Agati, V. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191656 · Cited by 485 · see citing works

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475 · see citing works

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

Liliensiek, B., Weigand, M. A., Bierhaus, A., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418704 · Cited by 468 · see citing works

Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

Cooper, M. E. (2001) · Diabetologia · doi:10.1007/s001250100000 · Cited by 375 · see citing works

Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42

Hudson, B. I., Kalea, A. Z., Arriero, M. D. M., Harja, E., Boulanger, É., D’Agati, V. D., & Schmidt, A. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801465200 · Cited by 361 · see citing works

Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy

Jha, J. C., Gray, S. P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070810 · Cited by 352 · see citing works

Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product–Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α–Dependent Pathway

Thallas‐Bonke, V., Thorpe, S. R., Coughlan, M. T., Fukami, K., Yap, F. Y. T., Sourris, K. C., Penfold, S. A., Bach, L. A., Cooper, M. E., & Forbes, J. M. (2007) · Diabetes · doi:10.2337/db07-1119 · Cited by 345 · see citing works

Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes

Yamagishi, S., Maeda, S., Matsui, T., Ueda, S., Fukami, K., & Okuda, S. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.03.014 · Cited by 296 · see citing works

The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.

Miyata, T., Hori, O., Zhang, J., Yan, S. S., Ferran, L., Iida, Y., & Schmidt, A. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118889 · Cited by 278 · see citing works

Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes

Stern, D., Yan, S. D., Yan, S. D., & SCHMIDT, A. (2002) · Ageing Research Reviews · doi:10.1016/s0047-6374(01)00366-9 · Cited by 267 · see citing works

RAGE in tissue homeostasis, repair and regeneration

Sorci, G., Riuzzi, F., Giambanco, I., & Donato, R. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.10.021 · Cited by 229 · see citing works

AGEs activate mesangial TGF-β–Smad signaling via an angiotensin II type I receptor interaction

Fukami, K., Ueda, S., Yamagishi, S., Kato, S., Inagaki, Y., Takeuchi, M., Motomiya, Y., Bucala, R., Iida, S., Tamaki, K., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66004.x · Cited by 218 · see citing works

Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS

Yamamoto, Y., Harashima, A., Saito, H., Tsuneyama, K., Munesue, S., Motoyoshi, S., Han, D., Watanabe, T., Asano, M., Takasawa, S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002253 · Cited by 207 · see citing works

Podocyte Lesions in Patients With Obesity-Related Glomerulopathy

Chen, H., Liu, Z.-H., Zeng, C., Li, S., Wang, Q., & Leishi, L. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.07.025 · Cited by 193 · see citing works

Role of AGEs-RAGE System in Cardiovascular Disease

Fukami, K., Yamagishi, S., & Okuda, S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990475 · Cited by 193 · see citing works

Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice

Flyvbjerg, A., Denner, L., Schrijvers, B. F., Tilton, R. G., Mogensen, T. H., Paludan, S. R., & Rasch, R. (2004) · Diabetes · doi:10.2337/diabetes.53.1.166 · Cited by 187 · see citing works

Insulin Resistance, Elevated Glomerular Filtration Fraction, and Renal Injury

Dengel, D. R., Goldberg, A. P., Mayuga, R. S., Kairis, G., & Weir, M. R. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.127 · Cited by 159 · see citing works

Role of AGEs in Diabetic Nephropathy

Fukami, K., Yamagishi, S., Ueda, S., & Okuda, S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784139710 · Cited by 150 · see citing works

Angiogenesis in autosomal-dominant polycystic kidney disease

Bello-Reuss, E. N., Holubec, K., & Rajaraman, S. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00768.x · Cited by 142 · see citing works

Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications

Yamagishi, S., Nakamura, K., Matsui, T., Ueda, S., Fukami, K., & Okuda, S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.7.983 · Cited by 138 · see citing works

RAGE and the pathogenesis of chronic kidney disease

D’Agati, V. D., & Schmidt, A. M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.54 · Cited by 135 · see citing works

Interactions between Renin Angiotensin System and Advanced Glycation in the Kidney

Thomas, M. C., Tikellis, C., Burns, W. M., Bialkowski, K., Cao, Z., Coughlan, M. T., Jandeleit-Dahm, K. A. M., Cooper, M. E., & Forbes, J. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010013 · Cited by 135 · see citing works

Targeted reduction of advanced glycation improves renal function in obesity

Harcourt, B. E., Sourris, K. C., Coughlan, M. T., Walker, K. Z., Dougherty, S. L., Andrikopoulos, S., Morley, A. L., Thallas‐Bonke, V., Chand, V., Penfold, S. A., et al. (2011) · Kidney International · doi:10.1038/ki.2011.57 · Cited by 122 · see citing works

Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus

Ma, C., Jiao, Y., Zhang, J., Yang, Q., Zhang, Z., Shen, Y., Chen, Z., & Zhao, Y. (2010) · Rheumatology International · doi:10.1007/s00296-010-1636-6 · Cited by 115 · see citing works

Autoantibody Induction by DNA-Containing Immune Complexes Requires HMGB1 with the TLR2/MicroRNA-155 Pathway

Wen, Z., Xu, L., Chen, X., Xu, W., Yin, Z., Gao, X., & Xiong, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203301 · Cited by 98 · see citing works

Dose-Dependent Effects of Sirolimus on mTOR Signaling and Polycystic Kidney Disease

Novalić, Z., van der Wal, A. M., Leonhard, W. N., Koehl, G. E., Breuning, M. H., Geissler, E. K., de Heer, E., & Peters, D. J. M. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040340 · Cited by 93 · see citing works

β2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts

Owen, W. F., Hou, F. F., Stuart, R. O., et al. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00882.x · Cited by 91 · see citing works

Expression of receptors for advanced glycosylated end-products in renal disease

Abel, M., Ritthaler, U., Zhang, Y., Deng, Y., Schmidt, A. M., Greten, H. J., Sernau, T., Wahl, P. R., Andrássy, K., Ritz, E., et al. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.9.1662 · Cited by 83 · see citing works

DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy

Kaida, Y., Fukami, K., Matsui, T., Higashimoto, Y., Nishino, Y., Obara, N., Nakayama, Y., Ando, R., Toyonaga, M., Ueda, S., et al. (2013) · Diabetes · doi:10.2337/db12-1608 · Cited by 78 · see citing works

Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice

Jensen, L. J. N., Denner, L. A., Schrijvers, B. F., et al. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06524 · Cited by 76 · see citing works

Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression

Matsui, T., Yamagishi, S., Takeuchi, M., Ueda, S., Fukami, K., & Okuda, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.07.004 · Cited by 64 · see citing works

Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations

Abdulahad, D. A., Westra, J., Bijzet, J., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4015 · Cited by 62 · see citing works

Immune complexes activate human endothelium involving the cell-signaling HMGB1-RAGE axis in the pathogenesis of lupus vasculitis

Sun, W., Jiao, Y., Cui, B., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.61 · Cited by 61 · see citing works

The Axis AGE-RAGE-Soluble RAGE and Oxidative Stress in Chronic Kidney Disease

Gugliucci, A., & Menini, T. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_14 · Cited by 56 · see citing works

Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis

Martens, H., Nienhuis, H. L. A., Gross, S., van der Steege, G., Brouwer, E., Berden, J., de Sévaux, R. G. L., Derksen, R. H. W. M., Voskuyl, A. E., Berger, S., et al. (2012) · Lupus · doi:10.1177/0961203312444495 · Cited by 56 · see citing works

The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis

Sadik, N. A. H., Mohamed, W., & Ahmed, M. I. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1001-4 · Cited by 51 · see citing works

Autosomal dominant polycystic kidney disease.

Lieske, J. C., & Toback, F. G. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v381442 · Cited by 51 · see citing works

Relationship between the Expression of Advanced Glycation End-Products (AGE) and the Receptor for AGE (RAGE) mRNA in Diabetic Nephropathy

Suzuki, D., Toyoda, M., Yamamoto, N., Miyauchi, M., Katoh, M., Kimura, M., Maruyama, M., Honma, M., Umezono, T., & Yagame, M. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1557 · Cited by 50 · see citing works

Advanced Glycation End Products and Receptor for Advanced Glycation End Products in AA Amyloidosis

Röcken, C., Kientsch-Engel, R., Mansfeld, S., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63917-x · Cited by 46 · see citing works

Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice

Hagiwara, S., Gohda, T., Tanimoto, M., Ito, T., Murakoshi, M., Ohara, I., Yamazaki, T., Matsumoto, M., Horikoshi, S., Funabïki, K., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.033 · Cited by 41 · see citing works

Clinical and pathological analysis of the kidney in patients with hypertensive nephropathy

Wang, X.-C., Liu, C., CHEN, Y.-J., Wu, Y., YANG, L.-S., Liu, H., & LIAO, H.-L. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1306 · Cited by 41 · see citing works

Effects of Specific Genes Activating RAGE on Polycystic Kidney Disease

Park, E. Y., Seo, M. J., & Park, J. H. (2010) · American Journal of Nephrology · doi:10.1159/000315859 · Cited by 39 · see citing works

Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy

Fukami, K., Yamagishi, S., Coughlan, M. T., Harcourt, B. E., Kantharidis, P., Thallas‐Bonke, V., Okuda, S., Cooper, M. E., & Forbes, J. M. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-86 · Cited by 39 · see citing works

Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis

Brodska, H. L., Malíčková, K., Valenta, J., Fabio, A., & Drábek, T. (2013) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2013.849357 · Cited by 36 · see citing works

Lupus nephritis

Lorenz, G., Desai, J., & Anders, H. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000444816.57378.21 · Cited by 35 · see citing works

Pattern of End Stage Renal Disease in a Tertiary Care Center

Khakurel, S., Agrawal, R. K., & Hada, R. (2009) · Journal of Nepal Medical Association · doi:10.31729/jnma.227 · Cited by 33 · see citing works

Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes

Tesch, G. H., Sourris, K. C., Summers, S. A., McCarthy, D. A., Ward, M. S., Borg, D. J., Gallo, L. A., Fotheringham, A. K., Pettit, A. R., Yap, F. Y. T., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3291-z · Cited by 31 · see citing works

Telmisartan inhibits AGE-induced podocyte damage and detachment

Fukami, K., Yamagishi, S., Kaifu, K., Matsui, T., Kaida, Y., Ueda, S., Takeuchi, M., Asanuma, K., & Okuda, S. (2013) · Microvascular Research · doi:10.1016/j.mvr.2013.04.006 · Cited by 29 · see citing works

Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression

Liebisch, M., Bondeva, T., Franke, S., Daniel, C., Amann, K., & Wolf, G. (2014) · Kidney International · doi:10.1038/ki.2014.3 · Cited by 26 · see citing works

Clinical Study of Advanced Glycation End Products in Egyptian Diabetic Obese and Non-Obese Patients

Amin, M. N., Mosa, A. A., & El‐Shishtawy, M. M. (2011) · International Journal of Biomedical Science · doi:10.59566/ijbs.2011.7191 · Cited by 26 · see citing works

Pioglitazone Improves Obesity Type Diabetic Nephropathy: Relation to the Mitigation of Renal Oxidative Reaction

Hirasawa, Y., Matsui, Y., Yamane, K., et al. (2008) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.57.423 · Cited by 22 · see citing works

Agents in development for the treatment of diabetic nephropathy

Fukami, K., Cooper, M. E., & Forbes, J. M. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.3.279 · Cited by 18 · see citing works

Targeting of Receptor for Advanced Glycation End Products Suppresses Cyst Growth in Polycystic Kidney Disease

Park, E. Y., Kim, B. H., Lee, E. J., Chang, E., Kim, D. W., Choi, S. Y., & Park, J. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.514166 · Cited by 18 · see citing works

Advanced glycation end product is implicated in amyloid‐related kidney complications

Matsunaga, N., Anan, I., Rosenberg, P. M., Nagai, R., Lundström, O., Horiuchi, S., Ando, Y., & Suhr, O. B. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510510013794 · Cited by 15 · see citing works

Investigation of AGE, their receptor and NF-kappaB activation and apoptosis in patients with ATTR and Gelsolin amyloidosis.

Anan, I., Kiuru‐Enari, S., Obayashi, K., et al. (2010) · PubMed · doi:10.14670/hh-25.691 · Cited by 10 · see citing works

Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury

Rungratanawanich, W., Qu, Y., Wang, X., Essa, M. M., & Song, B.-J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00561-7 · Cited by 411 · see citing works

The Modern Western Diet Rich in Advanced Glycation End-Products (AGEs): An Overview of Its Impact on Obesity and Early Progression of Renal Pathology

Bettiga, A., Fiorio, F., Di Marco, F., Trevisani, F., Romani, A., Porrini, E., Salonia, A., Montorsi, F., & Vago, R. (2019) · Nutrients · doi:10.3390/nu11081748 · Cited by 127 · see citing works

Glycation of human γB-crystallin: A biophysical investigation

Chaudhury, S., Ghosh, P., Parveen, S., et al. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.12.041 · Cited by 8 · see citing works

Skin Aging, Glycation and Glycation Inhibitors

Farris, P. K. (2013) · doi:10.1002/9781118384824.ch17 · Cited by 2 · see citing works

Differential glycation of rat α-, β- and γ-crystallins

Swamy, M. S., & Abraham, E. C. (1991) · Experimental Eye Research · doi:10.1016/0014-4835(91)90040-l · Cited by 30 · see citing works

Glycation of Human Lens Crystallins: Effect of Age and Aspirin Treatment

Cherian, M., & Abraham, E. C. (2009) · Ophthalmic Research · doi:10.1159/000267336 · Cited by 13 · see citing works

[Biochemical properties and clinical significance of protein glycation products].

Staniszewska, M. M., & Gamian, A. (2003) · PubMed · Cited by 2 · see citing works